233 related articles for article (PubMed ID: 26478625)
1. Eliminating artificial trans fatty acids in Argentina: estimated effects on the burden of coronary heart disease and costs.
Rubinstein A; Elorriaga N; Garay OU; Poggio R; Caporale J; Matta MG; Augustovski F; Pichon-Riviere A; Mozaffarian D
Bull World Health Organ; 2015 Sep; 93(9):614-22. PubMed ID: 26478625
[TBL] [Abstract][Full Text] [Related]
2. Consumption of trans fats and estimated effects on coronary heart disease in Iran.
Mozaffarian D; Abdollahi M; Campos H; Houshiarrad A; Willett WC
Eur J Clin Nutr; 2007 Aug; 61(8):1004-10. PubMed ID: 17268422
[TBL] [Abstract][Full Text] [Related]
3. Contribution of Trans-Fatty Acid Intake to Coronary Heart Disease Burden in Australia: A Modelling Study.
Wu JH; Zheng M; Catterall E; Downs S; Thomas B; Veerman L; Barendregt JJ
Nutrients; 2017 Jan; 9(1):. PubMed ID: 28106762
[TBL] [Abstract][Full Text] [Related]
4. Estimated health benefits, costs, and cost-effectiveness of eliminating industrial trans-fatty acids in Australia: A modelling study.
Marklund M; Zheng M; Veerman JL; Wu JHY
PLoS Med; 2020 Nov; 17(11):e1003407. PubMed ID: 33137090
[TBL] [Abstract][Full Text] [Related]
5. Development and application of the TFA macrosimulation model: a case study of modelling the impact of trans fatty acid (TFA) elimination policies in Brazil.
Nilson EAF; Khandpur N; da Silva Gomes F
BMC Public Health; 2022 Nov; 22(1):2010. PubMed ID: 36324096
[TBL] [Abstract][Full Text] [Related]
6. Cost-effectiveness analysis of eliminating industrial and all trans fats in England and Wales: modelling study.
Pearson-Stuttard J; Hooton W; Critchley J; Capewell S; Collins M; Mason H; Guzman-Castillo M; O'Flaherty M
J Public Health (Oxf); 2017 Sep; 39(3):574-582. PubMed ID: 27613767
[TBL] [Abstract][Full Text] [Related]
7. Quantifying the Socio-Economic Benefits of Reducing Industrial Dietary Trans Fats: Modelling Study.
Pearson-Stuttard J; Critchley J; Capewell S; O'Flaherty M
PLoS One; 2015; 10(8):e0132524. PubMed ID: 26247848
[TBL] [Abstract][Full Text] [Related]
8. Intake of ruminant trans fatty acids and risk of coronary heart disease.
Jakobsen MU; Overvad K; Dyerberg J; Heitmann BL
Int J Epidemiol; 2008 Feb; 37(1):173-82. PubMed ID: 18077475
[TBL] [Abstract][Full Text] [Related]
9. [Trans-fatty acids--effects on coronary heart disease].
Karbowska J; Kochan Z
Pol Merkur Lekarski; 2011 Jul; 31(181):56-9. PubMed ID: 21870712
[TBL] [Abstract][Full Text] [Related]
10. Impact of Nonoptimal Intakes of Saturated, Polyunsaturated, and Trans Fat on Global Burdens of Coronary Heart Disease.
Wang Q; Afshin A; Yakoob MY; Singh GM; Rehm CD; Khatibzadeh S; Micha R; Shi P; Mozaffarian D;
J Am Heart Assoc; 2016 Jan; 5(1):. PubMed ID: 26790695
[TBL] [Abstract][Full Text] [Related]
11. Health effects of trans-fatty acids: experimental and observational evidence.
Mozaffarian D; Aro A; Willett WC
Eur J Clin Nutr; 2009 May; 63 Suppl 2():S5-21. PubMed ID: 19424218
[TBL] [Abstract][Full Text] [Related]
12. Intake of ruminant trans fatty acids and risk of coronary heart disease-an overview.
Jakobsen MU; Bysted A; Andersen NL; Heitmann BL; Hartkopp HB; Leth T; Overvad K; Dyerberg J
Atheroscler Suppl; 2006 May; 7(2):9-11. PubMed ID: 16713389
[TBL] [Abstract][Full Text] [Related]
13. Global Surveillance of trans-Fatty Acids.
Li C; Cobb LK; Vesper HW; Asma S
Prev Chronic Dis; 2019 Oct; 16():E147. PubMed ID: 31674304
[TBL] [Abstract][Full Text] [Related]
14. Dietary fatty acids and risk of coronary heart disease in men: the Kuopio Ischemic Heart Disease Risk Factor Study.
Virtanen JK; Mursu J; Tuomainen TP; Voutilainen S
Arterioscler Thromb Vasc Biol; 2014 Dec; 34(12):2679-87. PubMed ID: 25256234
[TBL] [Abstract][Full Text] [Related]
15. Consumption of industrial and ruminant trans fatty acids and risk of coronary heart disease: a systematic review and meta-analysis of cohort studies.
Bendsen NT; Christensen R; Bartels EM; Astrup A
Eur J Clin Nutr; 2011 Jul; 65(7):773-83. PubMed ID: 21427742
[TBL] [Abstract][Full Text] [Related]
16. [Quality of fat intake, atherosclerosis and coronary disease: effects of saturated and trans fatty acids].
Torrejón C; Uauy R
Rev Med Chil; 2011 Jul; 139(7):924-31. PubMed ID: 22051833
[TBL] [Abstract][Full Text] [Related]
17. A cross-sectional study on trans-fatty acids and risk markers of CHD among middle-aged men representing a broad range of BMI.
Nielsen BM; Nielsen MM; Jakobsen MU; Nielsen CJ; Holst C; Larsen TM; Bendsen NT; Bysted A; Leth T; Hougaard DM; Skogstrand K; Astrup A; Sørensen TI; Jess T
Br J Nutr; 2011 Oct; 106(8):1245-52. PubMed ID: 21736833
[TBL] [Abstract][Full Text] [Related]
18. Estimated effects of reducing dietary saturated fat intake on the incidence and costs of coronary heart disease in the United States.
Oster G; Thompson D
J Am Diet Assoc; 1996 Feb; 96(2):127-31. PubMed ID: 8557937
[TBL] [Abstract][Full Text] [Related]
19. Trans fatty acids and cardiovascular disease-epidemiological data.
Willett WC
Atheroscler Suppl; 2006 May; 7(2):5-8. PubMed ID: 16713753
[TBL] [Abstract][Full Text] [Related]
20. Role of trans fatty acids in health and challenges to their reduction in Indian foods.
Ghafoorunissa G
Asia Pac J Clin Nutr; 2008; 17 Suppl 1():212-5. PubMed ID: 18296340
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
